Adjunctive Human Urinary Kallidinogenase Enhances the Cognitive and Hemodynamic Outcomes of Anterior Circulation Stenting
Translational Stroke Research · 2025
DOI: 10.1007/s12975-025-01375-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Stroke Research, 2025. Verfasst von Liuting Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital, Sun Yat-Sen University; Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Maj…. Hauptthemen laut MEDLINE: Kallikreins, Stents, Hemodynamics, Cognition. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Chronic cerebral hypoperfusion due to anterior circulation stenosis contributes to cognitive decline. This study examined whether preoperative human urinary kallidinogenase (HUK) administration improves outcomes following percutaneous transluminal angioplasty with stenting (PTAS). In this prospective non-randomized controlled trial, 128 patients with severe anterior circulation stenosis were included in the HUK and control groups, respectively. The primary endpoint was change in Mini-Mental State Examination (MMSE) score at 90 days. Secondary outcomes included changes in Montreal Cognitive Assessment (MoCA) and National Institutes of Health Stroke Scale (NIHSS) scores, perfusion parameters, and inflammatory biomarkers. Propensity score adjustments addressed selection bias. Besides mechanical revascularization by PTAS, HUK pretreatment improved cognitive recovery (ΔMMSE, 5 vs. 2; adjusted p 0.05), with no mortality. Collectively, adjunctive HUK administration before PTAS in patients with anterior circulation stenosis was associated with greater cognitive improvement and enhanced microvascular hemodynamics, potentially through anti-inflammatory and perfusion-modulating effects. Larger randomized controlled trials are warranted to validate these associations and elucidate the underlying mechanisms.Trial registration: Chinese Clinical Trial Registry. URL: https://www.chictr.org.cn/ ; unique identifier: ChiCTR2100053351.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital, Sun Yat-Sen University; Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases; National Key Clinical Department and Key Dis…
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Hu, L., Yang, F., Shang, W., Yang, J., Chen, X., Tan, S., Chen, H., Zhang, J., Xing, S., & Fan, Y. (2025). Adjunctive Human Urinary Kallidinogenase Enhances the Cognitive and Hemodynamic Outcomes of Anterior Circulation Stenting. Translational Stroke Research. https://doi.org/10.1007/s12975-025-01375-9
Vancouver
Hu L, Yang F, Shang W, Yang J, Chen X, Tan S, et al. Adjunctive Human Urinary Kallidinogenase Enhances the Cognitive and Hemodynamic Outcomes of Anterior Circulation Stenting. Translational Stroke Research. 2025. doi:10.1007/s12975-025-01375-9
BibTeX
@article{Hu2025,
author = {Hu, Liuting and Yang, Fan and Shang, Wenjin and Yang, Jing and Chen, Xinran and Tan, Shuangquan and Chen, Hongbing and Zhang, Jian and Xing, Shihui and Fan, Yuhua},
title = {Adjunctive Human Urinary Kallidinogenase Enhances the Cognitive and Hemodynamic Outcomes of Anterior Circulation Stenting},
journal = {Translational Stroke Research},
year = {2025},
doi = {10.1007/s12975-025-01375-9}
}
EUVIMED